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ABSTRACT 
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The consolidation of fear memories is known to depend on a number of critical cellular 
processes including de novo protein synthesis and 26S proteasome-dependent protein 
degradation following auditory fear conditioning (Jarome et al., 2011; Kwapis et al., 
2011). Early work has suggested that protein degradation, mediated by the ubiquitin 
proteasome system (UPS), may regulate the requirement for de novo protein synthesis 
during memory consolidation (Jarome & Helmstetter, 2014). However, the precise way in 
which the UPS is able to regulate mechanisms of protein synthesis remain unclear. In the 
present set of experiments, we investigated the role of the protein phosphatase 2A (PP2A) 
in mediating the interaction between the UPS and learning-induced mechanisms of 
protein synthesis during fear memory consolidation. Here we show that post-training 
administration of the PP2A inhibitor, okadaic acid (OA), has no effect on auditory fear 
memory consolidation in the amygdala. Interestingly, we also found that simultaneous, 
intra-amygdala infusions of the proteasome inhibitor, clasto-lactacystin β-lactone 
(BLAC), and OA can prevent the memory impairment that results from proteasome 
inhibition alone. However, in a final experiment we found that inhibition of PP2A and 
proteasome activity is not sufficient to rescue the BLAC-induced reduction of 
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phosphorylated ERK seen 60 min after auditory fear conditioning. Together, these data 
suggest that PP2A may mediate the interaction between the UPS and mechanisms of 
learning-induced protein synthesis, outside of the ERK signaling pathway, during the 
consolidation of auditory fear memories in the amygdala. 
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 Pavlovian fear conditioning has been an invaluable tool for investigating the 
neural mechanisms that support learning and memory.  In this paradigm, an initially 
innocuous conditioned stimulus (CS) is paired with an aversive unconditioned stimulus 
(UCS). Over several pairings, the animal develops a fear memory of the CS so that 
presentations of the CS alone are enough to cause the subject to emit a fear response, 
termed the conditioned response (CR). In many cases, the magnitude or frequency of the 
fear response in the presence of the CS is used as an indicator of learning (Fanselow, 
1980).  While there are many variations of Pavlovian fear conditioning, standard auditory 
delay fear conditioning is one of the most well understood.  This particular variation of 
fear learning is rapidly acquired, easy to measure and importantly, is known to rely on a 
well characterized neural circuit (Phillips & LeDoux, 1992; Sacchetti et al., 1999).   
 It is generally accepted that auditory fear conditioning is critically dependent 
upon activity and synaptic plasticity in the amygdala (Fanselow and LeDoux, 1999; 
Wilensky et al., 2006; Helmstetter et al., 2008; Pape and Pare, 2010). Several early 
studies showed that neurotoxic lesions made to the amygdala severely impair the 
formation of an auditory fear memory (Helmstetter, 1992; Maren, 1999).  Moreover, 
transient inactivation of the amygdala with the γ-Aminobutyric acid (GABA) receptor 
agonist, muscimol, before auditory or contextual fear conditioning significantly impairs 
auditory fear memory formation (Helmstetter & Bellgowan, 1994; Wilensky et al., 1999). 
Together, these data demonstrate that selective activation of the amygdala is critical for 
fear learning.   
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Protein synthesis and long-term memory formation 
 Indeed, several cellular mechanisms have been identified to be necessary for fear 
memory acquisition and consolidation. For example,  intra amygdala infusions of  (2R)-
amino-5-phosphonovaleric acid (AP5), a selective inhibitor of the N-methyl D-aspartate 
(NMDA) receptor, prior to auditory fear conditioning significantly impairs fear memory 
formation (Goosens & Maren, 2003).  Furthermore, other studies have shown the 
importance of additional cellular mechanisms within the amygdala to the formation of 
auditory fear memories. For example, de novo protein synthesis has been repeatedly 
demonstrated to be critical to fear memory formation. The blockade of protein synthesis 
in the amygdala, dose-dependently impairs the formation and consolidation of both 
contextual and auditory fear memories (Schafe et al. 1999). In fact previous work has 
shown that both pre and post training infusions of the protein synthesis inhibitor, 
anisomycin, severely impair the acquisition and consolidation of fear memory, 
respectively (Schafe et al. 1999; Schafe & LeDoux, 2000; Kwapis et al., 2011).  
 While anisomycin is an effective inhibitor of protein synthesis, blocking up to 
50% of total mRNA translation in vivo (Parsons et al., 2006), its use has been frequently 
criticized.  In a 2008 paper, Rudy and colleagues disparage the use of anisomycin to 
investigate memory formation, citing a variety of non-specific, negative effects on 
cellular functioning as a result of anisomycin administration. Furthermore, anisomycin's 
method of action is through inhibition of peptidyl transferase activity of the 80S ribosome 
system, which subsequently prevents the elongation of nascent peptides. Since this 
method of action occurs at the level of the ribosome, anisomycin is able to inhibit protein 
synthesis initiated through several different signaling pathways. This creates difficulty in 
3 
 
 
 
identifying specific pathways involved in the initiation of activity-dependent mRNA 
translation.  To address this, some studies have abandoned anisomycin in favor of 
translation inhibitors that act upon specific translation initiation signaling pathways such 
rapamycin, which is a selective inhibitor of the mammalian target of rapamycin complex 
1 (mTORC1) signaling cascade.  
 The mammalian target of rapamycin (mTOR) is the mammalian orthologue of a 
highly conserved serine/threonine kinase, TOR (target of rapamycin), found in yeast.  In 
mammals, the mTOR kinase can be associated with various scaffold and regulatory 
proteins to form two functionally distinct complexes (Costa-Mattioli & Monteggia, 
2013). Association of mTOR with with the protein called raptor, forms the mTOR 
complex 1 (mTORC1), while association with the rictor protein forms the mTOR 
complex 2 (mTORC2). Studies have shown that mTORC1 signaling is critical for cell 
growth and proliferation through the initiation of cap-dependent translation, whereas 
mTORC2 function is involved in actin organization and polymerization (Hoeffer & 
Klann, 2010; Huang et al. 2013).  In neurons, activation of mTORC1 occurs through its 
phosphorylation in response to a variety of synaptic plasticity associated events including 
stimulation of up-stream activators by brain-derived neurotrophic factor (BDNF) or 
NMDA receptor activation (Gong et al., 2006; Slipczuk et  al. 2009).   
 Activation of mTORC1 leads to subsequent phosphorylation of its downstream 
effectors, p70 ribosomal S6 kinase (p70S6K) and the 4E-binding protein (4EBP1). The 
mTOR-dependent phosphorylation of threonine-389 (Thr-389) on p70S6K results in its 
activation leading to subsequent ribosomal activation and mRNA translation. 
Furthermore, hyperphosphorylation of 4EBP1 by mTORC1 releases 4EBP1 from 
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eukaryotic translation initiation factor 4E (eIF4E), leading to cap-dependent mRNA 
translation (Raught et al., 2001; Huang, Bjornsti, & Houghton, 2003). Importantly, 
mTORC1 activity is sensitive to inhibition by its name-sake inhibitor, rapamycin. When 
rapamycin is present, it complexes with the immunophilin, FKBP12. This complex is 
able to tightly bind to the FKBP12-rapamycin binding (FRB) domain on mTOR and 
subsequently inhibit the formation of mTORC1 thus impairing downstream signaling 
through this pathway (Kim et al. 2002; Huang, Bjornsti, and Houghton, 2003; Hoeffer & 
Klann, 2010).  Importantly, the functionally distinct mTOR complex 2 (mTORC2) is 
rapamycin insensitive. This characteristic difference between mTORC1 and mTORC2 
allows for the specific manipulation of signaling through mTORC1.  
 Several studies have demonstrated that activity-dependent mTORC1 signaling is 
critical for memory formation. In the dorsal hippocampus, post-training rapamycin 
infusions  significantly impaired long term (LTM) but not short term memory (STM) 
formation for a one-trial inhibitory avoidance task and contextual fear conditioning 
(Bekinschtein et al. 2007; Gafford et al. 2011).  Additionally, inhibition of mTORC1 in 
the dorsal hippocampus or amygdala dramatically impairs LTM but not STM 
consolidation following a novel-object recognition task (Jobim et al., 2012).  In the same 
vein, previous work from our lab has shown that intra-amygdala infusions of rapamycin 
selectively impair the formation of an auditory fear memory. Interestingly, the same 
manipulation results in significantly reduced p70S6k activation and subsequent mRNA 
translation (Parsons et al., 2006).  Although the rapamycin-dependent reduction in 
mRNA translation was found to be significantly smaller than the reduction induced by 
anisomycin, since rapamycin infusions were found to impair fear memory formation, it 
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can be concluded that mTORC1-dependent mRNA translation is critically involved in 
memory consolidation and synaptic plasticity.  
 In addition to mTOR signaling, the role of the mitogen-activated protein family of 
kinases (MAPKs) in memory formation and synaptic plasticity has grown considerably in 
the last decade. Members of this kinase family include but are not limited to the p38 
MAP kinase, which is involved in stress-related signaling as a response to injury, and the 
extracellular signal-regulated kinases 1 and 2 (ERK 1/2; Roux & Blenis, 2004).  Several 
studies have implicated ERK 1/2 signaling as a critical regulator of cell proliferation and 
survival (Roskoski, 2012). As such, it has garnered much attention as another potential 
initiator of mRNA translation involved in memory consolidation. In neurons, ERK 1/2 is 
activated the Ras-Raf-MEK-ERK pathway in response to various plasticity associated 
growth factors, neurotrophins and calcium influx (Kelleher et al., 2004; Roskoski, 2012).  
The involvement of ERK1/2 signaling in transcription has been well studied. Activation 
of this pathway can lead to the translocation of ERK 1/2 to the nucleus and subsequent 
activation of a variety of transcription factors including cAMP response element binding 
protein (CREB) and the ternary complex factor Elk-1 (Davis et al., 2000).  
 However, ERK1/2 also maintains a critical role in initiating mRNA translation. 
This is characterized by ERK1/2-dependent phosphorylation of several downstream 
targets including 4EBP1, eukaryotic translation initiation factor 4E (eIF4E), and several 
ribosomal S6 kinases including p70 and p90 (p70S6K; p90RSK1; Roskoski, 2012).  
Interestingly, in the learning and memory literature manipulations that selectively knock-
out or impair activation of any of the aforementioned ERK targets severely impairs 
memory formation and consolidation (Antion et al., 2008; Hoeffer et al., 2011). Together 
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this information identifies the ERK1/2 signaling cascade as another cellular pathway 
critical for memory formation and consolidation.  
 Early work by Schafe et al. (2000) showed that ERK phosphorylation was 
increased roughly 60 min after auditory fear conditioning.  This time-course is similar to 
other pathways critical to memory formation such as mTORC1 (Parsons et al., 2006; 
Reis & Helmstetter, preliminary data, see figure 2). Importantly, Schafe and colleagues 
found that preventing the activation of ERK in the amygdala with the MEK inhibitor 
U0126 significantly impaired the consolidation of auditory fear memory. In addition, the 
prevention of ERK activation with U0126 significantly impaired long-lasting long-term 
potentiation (L-LTP), an in vitro model of memory consolidation (Schafe et al., 2000). 
Other studies have demonstrated similar memory impairments as a result of MEK 
inhibition with U0126 following a variety of behavioral paradigms such as auditory fear 
conditioning or inhibitory avoidance (Schafe et al., 2000; Igaz et al., 2006).  Further, 
Kelleher et al. (2004) generated mutant mice that expressed an inactive but structurally 
viable form of MEK1, the ERK 1/2 kinase. Following contextual fear conditioning, the 
mutant mice demonstrated selective impairment in long-term contextual fear memory. In 
addition, these mutant mice had noticeable reductions in phospho-eIF4E, and the mTOR 
targets phospho-S6K and phospho-4EBP1 compared to the control mice.  In support of 
this, others have shown that under certain conditions activation of ERK signaling is a 
prerequisite for the activation of mTOR (Fortress et al., 2013). This further supports the 
role of ERK signaling in memory and suggests that there may be some level of cross-over 
between mTORC1 and ERK 1/2 signaling.  
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 While there is clear evidence that signaling through mTOR and ERK is critical for 
mRNA translation-dependent memory consolidation, much less is known about how 
these mechanisms are regulated following learning.  Many of the up-stream activators of 
mTOR and ERK have been identified. Indeed, selective manipulation of many of these 
activators before or soon after behavioral training significantly alters the activation of 
mTORC1 or ERK1/2 and produces measurable changes in long-term memory (Banko et 
al., 2004; Merino & Maren, 2006; Chen et al., 2011).  Over-activation of translation 
regulating pathways has been strongly implicated in a variety of neuropathologies and 
disorders (Chong et al., 2010).  It is important to note that one way  this over activation  
can be prevented is through the actions  of negative regulators of these specific pathways. 
 One of the most common mechanisms of kinase inactivation is through 
desphosphorylation by various phosphatases such as calcineurin or protein phosphatase 
2A (PP2A). When active, these enzymes persistently work to dephosphorylate their target 
substrates. However, constitutively active phosphatases would be detrimental to general 
cellular function in addition to preventing most activity-induced signaling like that 
required for memory formation. Therefore, phosphatase activity must be selectively 
regulated to allow for dynamic control of critical signaling pathways. One possibility is 
that the mTORC1 and ERK 1/2 signaling cascades are regulated by the ubiquitin-
proteasome system (UPS) which modulates the activity of phosphatases that directly 
affect mTORC1 and ERK 1/2 signaling. 
The ubiquitin-proteasome and memory consolidation 
 The UPS is a known modulator of cell homeostasis during a wide range of 
cellular conditions such as cell differentiation, oxidative stress, and changes in nutrient 
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levels (Schmidt & Finley, 2014). In this system, a small protein called ubiquitin is 
covalently attached to various proteins destined for degradation. This attachment of the 
ubiquitin molecule to specific substrates occurs through the action of an enzymatic 
pathway that consists of 3 families of enzymes, termed E1, E2, and E3 (Hershko and 
Ciechanover, 1998).  Once a single ubiquitin is covalently attached, the pathway is then 
able to add additional ubiquitin molecules to the already substrate-bound ubiquitin. These 
successive ubiquitin molecules can be linked together at various lysine (K) residues of 
ubiquitin's C-terminus, thus creating a polyubiquitin chain. The specific lysine residue at 
which the ubiquitin molecules are linked can confer different functions of the 
polyubiquitin chain by acting as molecular signal for a variety of cellular processes 
(Deng et al., 2000; Ye and Rape, 2009).  Specifically, polyubiquitin chains of at least 4 
ubiquitin moieties linked together at their lysine-48 (K48) residues is considered to be the 
typical recognition signal for proteolysis via the proteasome (Thrower et al., 2000; 
Hegde, 2010). Proteins that are tagged with K48 polyubiquitin chains are targeted by the 
26S proteasome and subsequently degraded. 
 Some early work has demonstrated a significant contribution of the UPS to 
synaptic plasticity and long-term potentiation through its regulation of transcription and 
translation repressors (Uphadya et al., 2004; Dong et al., 2008).  More recently, work in 
our lab and others has shown that protein-degradation through the UPS is critical to 
memory formation and consolidation in  several brain structures (Artinian, et al. 2008, 
Jarome et al. 2011, Reis et al. 2013), further supporting its role as a general regulator of 
memory consolidation.  Jarome and colleagues (2011) found that degradation specific 
polyubiquitination was increased in the amygdala was significantly increased 60 min 
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after auditory fear conditioning and was maintained at this high level for at least 2 hrs 
after training.  Further, this increase was found to be learning-induced and NMDA 
receptor dependent as pre-training amygdala infusion of the NMDA receptor antagonist 
Ifenprodil severely reduced the amount of degradation specific polyubiquitination.  
Moreover, previous work has revealed that proteasome activity, in addition to 
degradation specific polyubiquitination, is increased 60 minutes after training. Similarly 
the phosphorylation of target proteins in the mTOR and ERK1/2 signaling pathways is 
also increased 60 minutes post-training lending further support to the idea that these 
pathways are regulated by the UPS (Schafe et al. 2000; Parsons et al. 2006; Jarome et al. 
2011).  
Protein phosphatase 2A as a target of the ubiquitin-proteasome system 
 Interestingly, several targets of the 26S proteasome have been identified 
following learning such as the post-synaptic density scaffolding protein, Shank  and the 
RNA-induced silencing complex (RISC), MOV10 (Jarome et al., 2011).  In cell culture, 
the catalytic subunit of the protein phosphatase 2A (PP2A-C) associates with the E3-
ubiquitin ligase, MID1 (Du et al., 2013).  PP2A-C is then polyubiquitinated and 
subsequently degraded by the proteasome. Although this was identified in cell culture 
there are great potential implications to the learning and memory literature.  Liu et al. 
(2011) showed that PP2A negatively affects the activity of the mTORC1 holoenzyme by 
disrupting the association of mTOR with raptor. Administration of a PP2A inhibitor 
okadaic acid (OA) prevents this disruption and promotes mTORC1 signaling. Inhibition 
of proteasome activity by MG132 significantly increased the level of PP2A-C and 
decreased the phosphorylation of down-stream targets of mTOR like S6 and 4EBP1 
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(Ghosh et al., 2008; Liu et al., 2011). Importantly, co-administration of MG132 and OA 
rescued the MG132 induced impairment in mTORC1 function (Liu et al., 2011).  
 It is clear that both activity-dependent proteolysis through the UPS and de novo 
protein synthesis are critical mechanisms for the consolidation of auditory fear memories 
in the amygdala. However, it remains unclear whether these two primary mechanisms of 
memory formation are independent of each other or whether they functionally 
complement each other.  
Much of the work investigating pathway interactions between the UPS and mTORC1 or 
ERK 1/2 signaling have used LTP or cell cultures as the primary model for investigation. 
In a preliminary study from our lab we investigated whether similar interactions occurred 
in vivo in an activity-dependent manner following auditory delay fear conditioning. 
Preliminary Study 1 and 2 
  In this study, twenty-six male Long Evans rats were bilaterally implanted with 
stainless steel cannula aimed at the basolateral nucleus of the amygdala. Following a 7-
day recovery period, the rats were trained in auditory delay fear conditioning in which 
there were four pairings of a 10-s white noise CS and a 1-s footshock UCS. Immediately 
after training, rats received bilateral infusions of the proteasome inhibitor, lac (n=9), the 
protein synthesis inhibitor, anisomycin (ANI; n=8) or 2% DMSO in aCSF (n=9). Figure 
1C shows the mean percent time freezing during the long-term memory test for the CS 24 
hr after training. Post-training infusion of ANI or lac into the amygdala significantly 
impairs freezing to the CS when presented 24 hrs after training.  Consistent with previous 
studies, this data supports the idea that ubiquitin-proteasome mediated proteolysis is a 
critical component in the initial formation and consolidation of long-term fear memories. 
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Figure 1: UPS-mediated proteolysis and de novo protein synthesis in the amygdala are 
critical for auditory fear memory formation. A) The behavioral training paradigm. B) The 
mean percent of time spent freezing during each period of the training session. C) 
Infusions of anisomycin or LAC significantly impaired memory for the CS. 
 
 To investigate the effect of proteasome inhibition on signaling through mTOR 
and ERK 1/2, an additional twenty-five male Long Evans rats were bilaterally implanted 
with stainless steel cannula aimed at the BLA. Following a recovery period, rats were 
trained in 4-trial auditory delay fear conditioning. Immediately after training, rats 
received bilateral infusions of LAC (n=9; 32 ng/l; from Sigma Chemical, St. Louis, 
MO, USA) or VEH (n=8; 2% DMSO in aCSF). The remaining animals were not trained 
but did receive bilateral infusions of VEH and served as the home cage control group 
(HC VEH; n= 8). Approximately 60 min after training, animals were sacrificed and the 
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brains were removed. The amygdala from each animal was dissected, homogenized in 
lysis buffer and subsequently analyzed with western blots 
 
Figure 2: Post-training proteasome inhibition in the amygdala dramatically reduces the 
level of phospho-ERK 1/2 (A), phospho-p70S6K (B), phospho-CAMKII (C), and 
phospho-PKA (D) in the amygdala 60 minutes after training. 
 
 Interestingly, western blot analysis revealed significant alterations in the 
phosphorylation status of several signaling molecules critical to activity-dependent de 
novo protein synthesis, following proteasome inhibition. Figure 2 (A-D) shows a 
dramatic reduction in the level of phosphorylated ERK 1/2, phospho-p70S6K, phospho-
CAMKII, and phospho-PKA approximately 60 min after training as a result of 
proteasome inhibition. This is the first evidence in vivo showing an interaction between 
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the ubiquitin-proteasome system and signaling mechanisms involved in translation 
initiation critical to synaptic plasticity.  While this study is ongoing, the preliminary data 
strongly support previous literature and suggests that the UPS is regulating activity-
dependent mRNA translation, necessary for memory consolidation, through the 
mTORC1 or ERK 1/2 signaling pathways. 
 If proteasome inhibition is positively regulating de novo protein synthesis through 
mTORC1 or ERK 1/2 activation as evidenced by proteasome inhibition-dependent 
reduction in mTORC1 or ERK1/2 signaling, then identifying a target protein common to 
these pathways as well as the UPS is critical.  Data from our preliminary study and others 
suggests that UPS activity may be interacting with signaling cascades critical to 
translation initiation. Moreover, there is significant evidence supporting UPS regulation 
of PP2A. Given the interaction between PP2A and the mTORC1 and ERK 1/2 signaling 
pathways, PP2A might serve as an important link between the UPS and translation.   
 Therefore, we hypothesized that post-training inhibition of  PP2A would 1) 
enhance memory formation and consolidation,  2) increase the activation/phosphorylation 
of down-stream effectors in translation signaling cascades, specifically in the mTORC1 
and MAPK/ERK 1/2 pathways.  Additionally, we predicted that simultaneous inhibition 
of PP2A and the 26S proteasome after training would rescue the memory deficits that are 
observed when proteasome activity is inhibited alone (Jarome et al., 2011).  Data 
supporting our hypotheses would identify a critical link between activity-dependent 
proteolysis and mRNA translation during memory formation and consolidation. These 
data will ultimately provide further evidence supporting the UPS as a critical regulatory 
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mechanism of de novo protein synthesis during memory consolidation and further extend 
our understanding of how memories are initially formed and consolidated. 
Materials and Methods 
Subjects  
 Subjects were 102 male, Long Evans rats weighing ~300-350 grams and were 
obtained from Harlan (Madison, WI).  All animals were individually housed and given ad 
libitum access to food and water. The colony room was maintained on a 14:10 hr 
light/dark cycle with all experiments occurring during the light period.  All procedures 
were approved by the University of Wisconsin-Milwaukee Institutional Animal Care and 
Use Committee and complied with the ethical guidelines of the National Institutes of 
Health (NIH). 
Surgery  
 All animals that underwent surgery were implanted with bilateral, stainless steel 
guide cannulae (26 ga; Plastics One Inc) aimed at the basolateral nucleus of the amygdala 
(A.P. -2.9; M.L. +5.0; D.V. -7.0 from bregma). Coordinates were based on a rat brain 
atlas (Paxinos & Watson, 2007). Prior to surgery, each rat was anesthetized with 
isoflurane in 100% O2 (4% induction, 2% maintenance).  Cannulae were secured to the 
skull with a stainless steel screw, ethyl cyanoacrylate, and acrylic cement. Following 
surgery animals were returned to their homecage and given a 7 day recovery period 
before any subsequent behavioral test. 
Conditioning apparatus  
 All conditioning sessions occurred in a set of four identical Plexiglas and 
stainless-steel chambers each housed inside a separate sound-attenuating box.  Each outer 
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box was illuminated with a 7.5 watt house light and was ventilated with a small fan. The 
background noise level in each of these outer boxes ranged from 62-64 dB. The floors of 
the Plexiglas chambers in context A were made of evenly spaced stainless steel rods 
through which the footshock (UCS) was delivered. Between each set of rats, each 
chamber was cleaned and the inside wiped down with 5% ammonium hydroxide.  
 All behavioral tests were conducted in a shifted context (context B). The chamber 
floors in context B were composed of an opaque, white piece of plastic. The chambers of 
context B were wiped with 5% acetic acid before each test session. 
Drug preparation and infusions  
 In experiments 2 and 3 rats were give intra-amygdala infusions of vehicle (2% 
dimethylsulfoxide (DMSO), in artificial cerebral spinal fluid (aCSF)), clasto-Lactacystin 
β-lactone (BLAC; 32 ng/µl), okadaic acid (OA; 100 nM), or BLAC + OA cocktail. Each 
infusion was given at a rate of 0.5 µl/min with a total volume of 0.5 ul/side. The injectors 
remained in the guide cannulae for 90 s to ensure sufficient diffusion of the drug.  
Following drug infusion, the obdurators were re-inserted into the cannulae and the animal 
was returned to its home cage. 
Behavioral procedures 
 Experiment 1  
 Previous work in our lab has demonstrated that typical 4 trial delay fear 
conditioning (4 pairings of a 73dB white noise with a 1s, 1.0 mA footshock with a 90 s 
inter-trial interval) generally elicits high levels of freezing to the auditory cue when tested 
24 hrs after training. We hypothesized that post-training inhibition of PP2A in the 
amygdala will enhance auditory fear memory consolidation.  In order to detect a 
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behavioral enhancement, we needed to use a training paradigm that would elicit low 
levels of freezing in control animals when tested for fear to the CS 24 hr later. Therefore, 
this experiment sought to determine if reducing the amplitude of the footshock during 
fear conditioning was sufficient to produce moderate (~50% of the total CS presentation 
time) levels of freezing behavior at the 24 hr test. Moderate freezing behavior should 
allow for the detection of any potential behavioral enhancement or deficit in subsequent 
experiments. Animals in this experiment were trained with 4-trial delay fear conditioning 
with a footshock intensity of .2 mA (n=5), .5 mA (n=5), or 1.0 mA (n=5). Approximately 
24 hr after training, animals were tested for fear to the auditory cue and training context. 
Experiment 2 
 This experiment assessed whether 1) inhibition of proteasome activity in the 
amygdala impairs the formation and consolidation of an auditory fear memory in a weak-
training (DFCW)  protocol 2) inhibition of PP2A enhances fear memory formation, and 3) 
simultaneous inhibition of PP2A and the 26S proteasome rescues the behavior deficit 
seen from proteasome inhibition alone.  In this experiment 32 rats with chronic cannulae, 
aimed at the BLA, were trained in auditory fear conditioning as described above. 
Immediately after training, rats received bilateral infusions of the PP2A antagonist 
okadaic acid (n=8), the proteasome inhibitor BLAC (n=8), a cocktail of OA + BLAC 
(n=8), or vehicle (n=8).  Twenty-four hours after training, all animals were tested for 
memory to the CS.   
Experiment 3 
 This experiment was designed to address the possibility that 100 nM OA is 
insufficient to induce memory enhancement. Here 20 rats with chronic cannulae aimed at 
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the BLA underwent  DFCw. Immediately after training all animals received bilateral 
infusions of vehicle (n=5), 100 nM OA (n=5), 200 nM OA (n=5), or 400 nM OA (n=5). 
Twenty-four hours after training, all animals were tested for fear to the CS. 
Experiment 4 
 This experiment examined the effects of post-training inhibition of PP2A, 
proteasome, or both on mTOR and ERK 1/2 activation in the amygdala 60 minutes after 
training.  Thirty-five rats with chronic cannulae aimed at the BLA were used in this 
experiment. Twenty-eight rats were trained in auditory fear conditioning as described 
above. Immediately after training, rats received bilateral infusions of the either the PP2A 
antagonist okadaic acid (n=7), the proteasome inhibitor BLAC (n=7), a cocktail of OA + 
BLAC (n=7), or vehicle (n=7).  Approximately 60 min after training, animals were 
euthanized and amygdala tissue was dissected, homogenized and subject to analysis via 
western blots (see above for detailed method). A separate group of naive rats were 
removed from their home cages, given bilateral infusions of vehicle (n=7) and euthanized 
60 min later. These animals served as a home cage training control. The degree of mTOR 
and ERK activation will be inferred by the relative level of phosphorylation of several 
down-stream effectors in the mTORC1 and ERK (1/2) pathways as determine through 
western blot probing. These targets include phosphorylated p70S6K, phospho-4EBP1, 
phospho-mTOR, phospho-ERK (1/2), phospho-CREB, and phospho-PKA.   
Results: 
Experiment 1 
 The first experiment was designed to determine fear conditioning parameters that 
would result in moderate levels of freezing to the auditory cue when tested 24 hr after 
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training. Here animals were trained with 4 trial DFC using either a .2 mA, .5 mA, or 1.0 
mA footshock. Figure 1B shows the mean percentage of time spent freezing for each 
group during the three periods of training.  An analysis of variance (ANOVA) revealed a 
main effect of group in the CS-UCS period (F(2,12)=11.372, p=.002) and in the post 
period (F(2,9)=19.071, p=.001).  Post hoc  analysis using Fisher's Least Significant 
Difference (LSD) further revealed that animals given 1.0 mA footshocks during training 
froze significantly more during the CS-UCS period than animals given .2 mA(p=.001) or 
.5 mA (p=.003) footshocks.  Furthermore,  post hoc analyses revealed that animals given 
1.0 mA shocks during training froze significantly more during the post period than did 
animals given .2 mA (p<.001) or .5 mA (p=.002) footshocks.  
 Figure 3C shows the mean percentage of time spent freezing for each group 
during presentations of the CS in the absence of a footshock.  A one-way ANOVA 
revealed a main effect of group during the CS presentations (F(2,21)=9.494, p=.001).  
Post-hoc analysis using Fisher's LSD revealed that animals given .5 mA footshocks 
during training showed greater freezing to the CS 24 hrs after training than animals given 
.2 mA (p=.052) footshocks but froze less than animals given 1.0 mA (p=.032) 
footshocks.   
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Figure 3: Shock intensity predicts CR magnitude. The percent time spent freezing during 
each period of training (A) and during the 24 hr CS test for each group. * p=.05; + p=.052. 
 
 Importantly, these results indicate that auditory delay fear conditioning using a 73 
dB auditory CS and a .2 mA or .5 mA footshock is sufficient to produce a moderate level 
of freezing of approximately 50% when tested for fear to the CS 24 hrs after training.  
For the remaining experiments we chose to use a .3 mA footshock since our target 
amount of time spent freezing (50%)  falls between the amount seen in the .2 mA (M=43) 
and .5 mA (M=59) groups. 
Experiment 2 
 Next we wanted to investigate whether inhibition of PP2A in the amygdala 
enhances memory consolidation following DFCW and if co-inhibition of PP2A and the 
proteasome is sufficient to abrogate the previously documented BLAC-induced behavior 
deficit (Jarome et al., 2011). Here animals were trained with 4 trial DFCw and were given 
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immediate post-training bilateral infusions of VEH, BLAC, OA, or OA + LAC into the 
BLA.  Figure 4B shows the mean percent of time spent freezing during each period of the 
training session. A repeated measures ANOVA revealed a main effect of training period 
(F(1,3)=26.659, p<.001) indicating that all of the rats learned the CS-UCS association 
during the training session. Importantly, no main effect of group was found in the 
baseline period (F(3,28)=2.174, p=.113), the CS-UCS period (F(3,28)=.694, p=.564), or 
in the post period (F(3,28)=.390, p=.761).  
 
Figure 4: Co-infusion of BLAC and OA prevents memory deficits 24 hr after training. 
A) Schematic of the training and testing paradigm. B) Mean percent of time spent 
freezing for each group during each period of the training session. C) Mean percent of 
time spent freezing to 8 presentations of the CS. 
 
 Figure 4C shows the mean percentage of time spent freezing to the auditory cue 
during the CS test 24 hrs after training.  A one-way ANOVA revealed a significant main 
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effect of group on freezing to the CS (F(3,24)=7.294, p=.001).  In line with our 
preliminary data, Fisher's LSD further revealed that animals given post training infusions 
of Blac (M=37.7) froze significantly less during the CS presentations than animals given 
VEH (M=52.9; p=.018), OA (M=62.1; p<.001) or the cocktail of OA + BLAC (M=61.5; 
p=.001). However, in contrast with our hypothesis, post-training infusions of OA into the 
amygdala do not have an enhancing effect on fear memory consolidation since VEH 
freezing and OA freezing are not significantly different from each other.  Nevertheless, 
these results do suggest that simultaneous inhibition of PP2A and the 26S proteasome in 
the amygdala, is sufficient to rescue the behavioral deficit observed in the Blac group as 
OA + BLAC animals froze significantly more than animals given infusions of BLAC 
alone.  
Experiment 3 
 To address the possibility that the concentration of OA used in this experiment 
was not sufficient to induce memory enhancement, we trained rats with DFCw and 
administered post-training amygdala infusions of OA at concentrations of 100 nM (n=5), 
200 nM (n=5), 400 nM (n=5) or vehicle (n=5).   
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Figure 5: Increasing concentrations of OA do not effect memory consolidation. A) 
Schematic of the training and testing paradigm. B) Mean percent of time spent freezing 
during each period of the training session. C) Mean percent of time spent freezing to 8 
presentations of the CS.  
 
  
 
Figure 5B-C shows the mean percent of time spent freezing during training and the CS 
test 24 hrs after training. ANOVA revealed no significant main effect of dose during the 
baseline (F(3,16)=1.483, p=.257), CS-UCS (F(3,16)=1.130, p=.367) or the post 
(F(3,16)=.479, p=.701) period of the training session. Furthermore, there were no group 
differences in freezing to the auditory cue during the CS test (F(3,16)=.676, p=.579). This 
finding rules out the possibility that the lack of an OA-induced behavioral enhancement 
was due to an insufficient dosage of OA.  
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Experiment 4 
 Next we sought to investigate the effect of OA, BLAC, or OABL infusions into 
the amygdala on several cellular signaling pathways known to be involved in fear 
memory consolidation. Similar to experiment 2, rats were trained with 4 trial DFCw and 
received immediate post-training infusions of either VEH, BLAC, OA, or OABL before 
being sacrificed 60 min after training for western blot analysis (Figure 6A).   
 
Figure 6: Post-training okadaic acid infusion has no effect on phosphorylated ERK A) 
Animals were trained in 4 trial DFCW and sacrificed 60 min later for tissue analysis with 
western blots. B) Mean optical density of phosphorylated ERK. * indicated p=.05 
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 While data analysis for this experiment is ongoing, ANOVA revealed a main 
effect of group (F(4,27)=3.019, p=.035) on the phosphorylation of ERK (Figure 6B).  
Fisher LSD post hoc analysis revealed an increase in phospho-ERK, nearing statistical 
significance, 60 min after training in VEH (p=.081) infused animals relative to HC 
control animals. Consistent with our preliminary data, BLAC infusion blocks the 
training-induced increase in phospho-ERK (p=.036). While the level of  phospho-ERK is 
significantly attenuated following proteasome inhibition, simultaneous inhibition of 
PP2A and the 26S proteasome fails to prevent this BLAC-induced reduction, seen in the 
comparison of OABL (p=.924) to the BLAC. This is counter to our hypothesis and may 
suggest that the UPS modulates plasticity-related signaling pathways through multiple, 
pathway-specific regulatory mechanisms.  
Discussion: 
 Here we present data suggesting that the regulation of PP2A by the UPS is critical 
for fear memory consolidation in the amygdala following auditory delay fear 
conditioning. Similar to earlier work, we found that inhibiting proteasome activity in the 
amygdala immediately after training with a weak DFC protocol impaired fear memory 
consolidation for the auditory cue. Furthermore we found that inhibition of PP2A activity 
was not sufficient to enhance memory consolidation but that simultaneous inhibition of 
PP2A and proteasome activity in the amygdala is able to block the behavioral deficit 
caused by proteasome inhibition. Together these data suggest that PP2A may be involved 
in mediating the interaction between the UPS and protein synthesis signaling.    
 Given the established role of PP2A as a negative regulator of the mTOR and ERK 
signaling pathways, we hypothesized that inhibition of PP2A would enhance mTOR and 
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ERK signaling and consequently enhance fear memory consolidation.  Our results 
indicate that post-training infusion of OA into the amygdala does not enhance memory 
consolidation following DFCw.  Previous work using a conditioned taste aversion 
paradigm found that intra-amygdala infusions of OA enhanced memory only when 
administered 5 min prior to training but not when administered 5 min after training 
(Oberbeck et al., 2010).  This finding is consistent with other reports of temporally 
sensitive phosphatase activity for a variety of different learning models (Zhao et al., 
1995; Bennett et al., 1996; Genoux et al., 2002). Given that the present study did not 
investigate the effects of pre-training OA-infusions on fear memory, it is possible that 
post-training inhibition of PP2A falls outside of a window of phosphatase activity critical 
for the consolidation of fear memories. Future work is needed to evaluate the effects of 
pre-training intra-amygdala infusions of OA on fear memory formation and 
consolidation. 
 Earlier work has identified a critical role for protein synthesis and, more recently, 
UPS-mediated protein degradation in the consolidation of fear memories (Schafe et al., 
1999; Kwapis et al., 2011; Jarome et al., 2011). While the exact relationship between 
these two mechanisms remains unclear, recent evidence has suggested that UPS-mediated 
protein degradation may play a role in regulating activity-dependent protein synthesis 
during memory consolidation (Ehlers, 2003; Jarome et al., 2011).  Here we show that 
simultaneous blockade of UPS-mediated protein degradation and PP2A activity, in the 
amygdala, effectively prevents the BLAC-induced memory deficit. This finding is of 
particular interest given that OA was found to have no effect on the consolidation of an 
auditory fear memory, neither enhancing nor impairing the memory.  Our results support 
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the idea that PP2A may be at least one substrate through which the UPS is able to 
modulate mechanisms of protein synthesis during memory consolidation. 
 In the same vein, we examined the effects of OA and OABL on various cellular 
signaling pathways known to be critically involved in memory consolidation. While this 
experiment is ongoing, early data suggests the UPS may differentially regulate mTOR 
and ERK signaling during memory consolidation. Here we demonstrate that inhibition of 
PP2A has no effect on ERK phosphorylation. This finding is in disagreement with our 
hypothesis and incongruent with early reports of PP2A-regulated ERK (Meng et al., 
2015). Since our preliminary data indicate reductions in phosphorylated ERK and 
p70S6K as a result of proteasome inhibition but also since PP2A inhibition has no effect 
on ERK, it is possible that the UPS differentially regulates mTOR and ERK signaling 
during memory consolidation.  
 While further work is needed to extend the findings presented here and to better 
delineate the differential regulation that the UPS may have on mTOR and/or ERK 
signaling, the data presented here strongly support the involvement of PP2A as an 
important regulatory element during the consolidation of fear memories. 
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